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Apoptotic death of hepatocytes, a contributor to
many chronic and acute liver diseases, can be a
consequenceof overactivation of the immunesystem
and is often mediated by TNFa. Injection with
lipopolysaccharide (LPS) plus the transcriptional
inhibitor D(+)-galactosamine (GalN) or mitogenic
T cell activation causes fatal hepatocyte apoptosis
in mice, which is mediated by TNFa, but the effector
mechanisms remain unclear. Our analysis of gene-
targeted mice showed that caspase-8 is essential
for hepatocyte killing in both settings. Loss of Bid,
the proapoptotic BH3-only protein activated by
caspase-8 and essential for Fas ligand-induced
hepatocyte killing, resulted only in a minor reduction
of liver damage. However, combined loss of Bid and
another BH3-only protein, Bim, activated by c-Jun
N-terminal kinase (JNK), protected mice from
LPS+GalN-induced hepatitis. These observations
identify caspase-8 and theBH3-only proteinsBid and
Bim as potential therapeutic targets for treatment of
inflammatory liver diseases.
INTRODUCTION
Abnormal apoptotic death of hepatocytes is thought to be a cause
or contributing factor in many chronic as well as acute liver
diseases (reviewed in Bradham et al., 1998; Ding and Yin, 2004).
Tumor necrosis factor (TNFa), FasL, and related members of the
TNF cytokine family have been implicated in hepatocyte killing
but the signaling pathways contributing to development and
progression of these diseases are presently unclear. The molec-
ular basis of hepatocyte destruction in hepatitis can be studied56 Immunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc.withmousemodels. For example, injection of low doses of bacte-
rial lipopolysaccharide (LPS) in the presence of the liver-specific
transcriptional inhibitor D-(+)-galactosamine (GalN) or treatment
with the T cell mitogen concanavalin A (ConA) causes fatal hepa-
tocyte destruction. In both settings, TNFa is essential for hepato-
cyte killing and animal mortality (Pfeffer et al., 1993; Rothe et al.,
1993; independently confirmed by us for both treatments, see
Figure S1 available online). Secreted TNFa appears to be critical
in LPS+GalN-injected mice, whereas both secreted and
membrane-bound TNFa contribute to hepatocyte destruction in
ConA-injected animals (Grivennikov et al., 2005; Nowak et al.,
2000; Pfeffer et al., 1993; Rothe et al., 1993). The mechanisms by
which TNFa kills hepatocytes are still unclear. TNF-R1 has an
intracellular ‘‘death domain’’ and therefore belongs to the ‘‘death
receptor’’ subgroup within the TNF-R family, which also includes
Fas (APO-1 or CD95), DR3, and the TRAIL receptors DR4 and
DR5 (Ashkenazi andDixit, 1998).Geneticandbiochemicalstudies,
using fibroblasts from gene-targetedmice, have shown that TNF-
R1 triggers apoptosis by binding the adaptor proteins TRADDand
FADD,which facilitate recruitment and activation of the aspartate-
specific cysteine protease caspase-8 (Ashkenazi and Dixit, 1998).
Signaling through the c-JunN-terminal kinase (JNK) has alsobeen
implicated inTNFa-inducedapoptosis signaling (Baudetal., 1999;
Kamata et al., 2005; Wang et al., 2006), but the death effectors
acting downstream of JNK in this process have not yet been
identified.Caspase-8canproteolytically activate theproapoptotic
BH3-onlyBcl-2 familymemberBid (Li et al., 1998;Luoetal., 1998),
which triggers apoptosis by activating Bax and Bak (members of
the second proapoptotic subgroup within the Bcl-2 family), either
directly or indirectly by binding to prosurvival Bcl-2 family
members (e.g., Bcl-xL and Mcl-1) (Zha et al., 2000). Experiments
with gene-targeted mice have shown that caspase-8 and Bid
are both essential for Fas-induced apoptosis in hepatocytes,
although only caspase-8 but not Bid is required for killing of
T lymphoid cells (Kang et al., 2004; Kaufmann et al., 2007b;
Salmena et al., 2003; Yin et al., 1999).
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Roles of Caspase-8, Bid, and Bim in HepatitisThe roles of caspase-8 and Bid in TNFa-induced apoptosis are
still unclear, although Bid deficiency was shown to afford aminor
degree of protection in TNFa-treated mouse embryo fibroblasts
(MEFs) in vitro and in hepatocytes of mice injected with
LPS+GalN (Chen et al., 2007; Zhao et al., 2001). Notably, most
studies on TNFa-induced apoptosis have been performed with
cells in culture and very little is known about the mechanisms
by which overactivation of the immune system causes TNFa-
mediated immunopathological tissue destruction. Our experi-
ments with gene-targeted mice demonstrated that TNFa-medi-
ated hepatocyte apoptosis required caspase-8 and involved
the proapoptotic BH3-only proteins Bid, activated by caspase-8,
and Bim, activated by JNK, respectively. These cell-death
inducers and effectors can therefore be considered potential
therapeutic targets for immunopathological liver disorders.
RESULTS
Caspase-8 Is Essential for LPS+GalN-Induced
Hepatocyte Destruction
Experiments with gene-targeted mice demonstrated that
expression of caspase-8 within hepatocytes is essential for
Fas-antibody-induced hepatocyte killing and fatal hepatitis
(Kang et al., 2004). It is, however, not clear whether caspase-8
is also essential for pathological killing of hepatocytes by TNFa.
In fact, several studies with cultured cells have indicated that
TNFa kills cells by caspase-independent, perhaps even nona-
poptotic, mechanisms (reviewed in Ding and Yin, 2004). When
mice lacking caspase-8 selectively in hepatocytes (mice homo-
zygous for Casp8 gene flanked with loxP sites expressing a Cre
recombinase transgene under control of the hepatocyte-specific
albumin [Alb] promoter: Alb-Cre-Casp8fl/fl) were challenged with
LPS+GalN, they showed only minor elevation of ALT and AST in
the serum (Figure 1A) and retained normal liver structure (Fig-
ure 1B), and all mice survived long-term (Figure 1C). In contrast,
all littermate controls succumbed to this treatment within 8–10 hr
(Figure 1C), presenting at autopsy with abnormally elevated
serum ALT and AST levels (Figure 1A; Alb-Cre-Casp8fl/fl versus
controlmice: p < 0.015 for ALT, p < 0.0015 for AST) and extensive
disruption of liver architecture (Figure 1B). Consistent with these
observations, immunoblot analysis of liver extracts from
LPS+GalN-treated control animals revealed processing of Bid
(p22) into its active p15 form tBid as well as extensive processing
of caspase-3 and caspase-7, whereas no Bid cleavage and
no activation of effector caspases could be detected in
Alb-Cre-Casp8fl/fl mice (Figure S2).
Consistent with the experiments usingmice lacking caspase-8
in their hepatocytes, treatment of C57BL/6 (WT) mice with the
pan-caspase inhibitor Q-VD-oph resulted in significant (p <
0.01) protection from LPS+GalN-induced hepatitis, as assessed
by serum levels of ALT and AST as well as histological examina-
tion (Figures 1Dand1EandFigureS3A). However, administration
of Q-VD-oph, even at multiple dosages, afforded less protection
than loss of caspase-8 (compare Figure S3B with Figure 1C),
presumably because this treatment did not achieve complete
blockade of this enzyme. Similar to Fas-activation (Li et al.,
1998; Luo et al., 1998), injection of WT mice with LPS+GalN
caused rapid processing of pro-caspase-8 to produce the active
p18 fragment and cleavage of Bid (p22) into its active truncatedp15 form (tBid), as well as processing and activation of effector
caspases, such as caspase-7 (p17) (Figure 1F). No processing
of caspase-8, Bid, or effector caspases was seen in liver extracts
from LPS+GalN-injected mice lacking TNFa (Figure S4). Collec-
tively, these results demonstrate that upon LPS+GalN injection,
activation of caspase-8 within hepatocytes is required for
TNFa-mediated liver destruction and fatal hepatitis.
Bid Is a Minor Contributor to LPS+GalN-Induced
Hepatocyte Apoptosis
Caspase-8-mediated activation of Bid is essential for Fas-
antibody-induced liver destruction (Yin et al., 1999). We
confirmed this observation (Kaufmann et al., 2007b) and found
that Bid/ mice are also resistant to FasL (Figure S5). This is
an important finding because antibodies to Fas do not always
mimic the physiological ligand FasL (Huang et al., 1999).
Although Bid cleavage is readily detectable in the livers of
LPS+GalN-treated animals (Figure 1F), recently published data
indicate that, in contrast to Fas signaling (Kaufmann et al.,
2007a; Yin et al., 1999), TNFa-TNF-R1-induced hepatocyte
apoptosis may not be entirely dependent on Bid (Chen et al.,
2007). For evaluating the role of Bid in the in vivo killing of hepa-
tocytes by TNFa, WT and Bid/ mice were challenged with
various doses of LPS+GalN. Upon injection of very low doses
of LPS (10 ng) plus GalN, Bid/mice were clearly less severely
affected than WT animals. All WT mice succumbed within 6–8 hr
of treatment, whereas all Bid/mice remained alive and healthy
at that time, presenting with nearly normal ALT and AST serum
levels (Figure 2A; Bid/ versus WT: p < 0.0002 for ALT, p <
0.0001 for AST) and only minor liver destruction (Figure 2C).
However, only three out of seven Bid/mice survived this treat-
ment for 5 days (experiment stopped thereafter); the other four
became terminally ill within 24 hr (Figure 3C). Moreover, when
the dose of LPS was increased to 100 or 1000 ng, not only the
WT but also all Bid/ animals succumbed to this treatment
within 12 hr, although the serum levels of ALT and AST remained
significantly lower in the Bid/ mice compared to the WT litter-
mates (Figure 2B; p < 0.02 for ALT and p < 0.002 for AST).
Consistent with the serum levels of ALT and AST, histological
examination of liver sections taken after 6 hr showed extensive
hepatocyte destruction in Bid/ mice (albeit slightly less than
in WT controls) after injection of 100 or 1000 ng LPS+GalN
(Figure 2C). These results demonstrate that Bid contributes to
LPS+GalN-induced hepatocyte apoptosis, but its loss can only
delay but not prevent the fatal outcome of this TNFa-mediated
process.
Combined Loss of Bid and Bim Potently Protects Mice
from LPS+GalN-Induced Fatal Hepatitis
Not only Bid (Li et al., 1998; Luo et al., 1998) but also the related
BH3-only protein Bim (encoded by the Bcl2l11 gene, also called
Bim) was reported to be activated by caspase-mediated prote-
olysis (Chen and Zhou, 2004). Therefore, and because Bim plays
a major role in apoptosis in many cell types (Bouillet et al., 1999;
Huang and Strasser, 2000) and binds avidly to all prosurvival
Bcl-2 family members (Chen et al., 2005; Kuwana et al., 2005),
we examined whether Bid and Bim cooperate in TNFa-mediated
hepatocyte killing in vivo. Interestingly, Bcl2l11/ mice were
less sensitive to injection with 10 ng LPS+GalN (with two ofImmunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc. 57
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Roles of Caspase-8, Bid, and Bim in HepatitisFigure 1. LPS+GalN-Induced Hepatitis
Requires the Initiator Caspase, Caspase-8,
Is Inhibited by a Pan-Caspase Inhibitor,
and Involves Cleavage of the Proapoptotic
BH3-Only Bcl-2 Family Member Bid
(A) Mice lacking caspase-8 in hepatocytes
(albumin-Cre transgenic Casp8fl/fl) and littermate
controls (albumin-Cre transgenic Casp8fl/wt mice)
were injected with 100 ng LPS with the addition
of 20 mg GalN. At the time when the control
mice were terminally ill (8 hr), all animals were
sacrificed and serum levels of the liver transami-
nases ALT and AST measured. Data shown repre-
sent means ± SD of three to five mice for each
genotype.
(B) H&E-stained histological liver sections from
mice treated as in (A). Pictures shown are repre-
sentative of the analysis of at least three mice for
each treatment and genotype.
(C) Nine mice of the indicated genotypes in each
group were injected i.p. with LPS+GalN and
followed over 72 hr after injection. p values were
calculated with a time-to-event analysis with
a log-rank test. No mortality was observed in
mice of either genotype injected with 20 mg
GalN alone (n = 3 per genotype).
(D) Three control WT mice and three WT mice pre-
treated with 20mg/kg of the pan-caspase inhibitor
Q-VD-oph (i.p. injection 30 min prior to treatment)
were injected with 100 ng LPS with the addition of
20 mg GalN. All animals were sacrificed after 6 hr
and serum levels of ALT and AST measured. Each
circle represents measurements from an indi-
vidual mouse. Horizontal bars indicate the mean.
(E) H&E-stained histological liver sections from the
same mice treated in (D). Pictures shown are
representative of the analysis of three mice for
each treatment.
(F) WTmicewere injected with 100 ng LPSwith the
addition of 20 mg GalN and sacrificed after the
indicated time points. Processing of caspase-8,
Bid, caspase-7, and b-actin (loading control) was
examined by immunoblotting.five mice surviving long-term) than WT animals, although no
protection was evident when they were challenged with 100 ng
LPS+GalN (Figure 3C). Remarkably,Bcl2l11/Bid/micewere
more resistant than WT, Bcl2l11/, or Bid/ mice to both
10 and 100 ng LPS+GalN (Figure 3). At the time when all WT,
Bid/, and Bcl2l11/ mice were ill, serum ALT and AST levels
of Bcl2l11/Bid/ mice were significantly lower than those
found in the control animals (Figure 3A; Bcl2l11/Bid/ versus
WT mice, p < 0.03 for ALT, p < 0.035 for AST). Histological anal-
ysis confirmed reduced liver destruction in Bcl2l11/Bid/
mice compared to all control animals (Figure 3B). Furthermore,
eight out of eight Bcl2l11/Bid/ mice did not get sick when
treated with 10 ng LPS+GalN and survived long-term (followed
up to 5 days), a dose at which all WT mice succumbed within
6–8 hr and only three out of seven Bid/ mice and two out of
five Bcl2l11/ mice survived longer than 24 hr (Figure 3C).58 Immunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc.Remarkably, even at 100 ng LPS+GalN, a dose at which all WT
(12/12), all Bid/ (12/12), and all Bcl2l11/ (3/3) mice suc-
cumbed within 12 hr, five out of seven Bcl2l11/Bid/ mice
survived long-term (followed up to 5 days), even though some
went through phases of sickness during the first 24 hr of treat-
ment (Figure 3C and Figure S6). Consistent with the finding
that Bid and Bim have overlapping functions in LPS+GalN-
induced hepatocyte killing, immunoblotting (Figure S7A) and
fluorogenic-enzyme-activity assays (Figure S7B) showed that
loss of Bid and to a lesser extent loss of Bim both diminished
activation of effector caspases and that loss of both of these
BH3-only proteins caused significantly (p < 0.01) greater reduc-
tion, particularly at later time points. Synergy between loss of Bid
and loss of Bim appears to be specific to LPS+GalN-induced
(TNF-mediated) hepatocyte killing because fibroblasts and
T lymphocytes from Bcl2l11/Bid/mice were either normally
Immunity
Roles of Caspase-8, Bid, and Bim in Hepatitissensitive or no more resistant than Bcl2l11/ cells to a diverse
range of apoptotic stimuli (Willis et al., 2007 and T.K., P.B., and
A.S., unpublished data). These results demonstrate that the
two proapoptotic BH3-only proteins Bid and Bim cooperate in
TNFa-mediated hepatocyte apoptosis induced by treatment
with LPS+GalN.
Mechanisms of Activation of Bid and Bim during
LPS+GalN-Induced Hepatitis
Because Bid and Bim play critical overlapping roles in
TNFa-inducedapoptosis,we investigated how they are activated
in hepatocytes from animals injected with LPS+GalN. This treat-
ment caused rapid processing of Bid into the potently proapop-
totic truncated tBid form (Figures 1F and 4A). Loss of caspase-8
or pretreatment of WT mice with Q-VD-oph, which affords
substantial protection fromLPS+GalN-inducedhepatitis (Figures
1D and 1E and Figure S3), decreased the production of tBid in
LPS+GalN-injected mice and this correlated with a lack of pro-
caspase-8 processing and a complete lack of effector-caspase
activation (Figure 4A and Figure S2).
Although caspase-mediated activation of BimEL (the most
abundantly expressed isoformofBim in the liver andother tissues
[O’Reilly et al., 2000]) has been reported (Chen and Zhou, 2004),
Figure 2. Bid Contributes to LPS+GalN-
Induced Hepatitis
(A) Bid-deficient mice and WT controls were in-
jected i.p. with 10 ng of LPS+GalN (20 mg per
mouse) or with GalN alone as control. Mice were
sacrificed after 6 hr and bled, and serum ALT
and AST levels were measured. Each circle repre-
sents measurements from an individual mouse
(n indicates the numbers of mice analyzed for
each condition of treatments). Horizontal bars
indicate the mean.
(B) Bid-deficient mice and WT controls were
injected i.p. with increasing doses (10, 100, and
1000 ng) of LPS, all in the presence of 20 mg
GalN, and analyzed after 6 hr as in (A). Data are
presented as means ± SD.
(C) Histological examination of H&E-stained liver
sections of Bid/ and WT mice subjected to the
treatments indicated (scale bars represent
50 mm). Pictures shown are representative of the
analysis of at least three mice for each treatment
and genotype.
we found no evidence for BimEL cleavage
in livers of LPS+GalN-injected mice (Fig-
ures 4A and 5A). JNK-mediated phos-
phorylation has also been implicated in
the activation of Bim (Lei and Davis,
2003). Notably, a mobility shift in BimEL
in liver extracts was observed soon after
injection with LPS+GalN (Figures 4A and
5A and Figure S4). Treatment of these
extracts with l-phosphatase demon-
strated that the modification of Bim was
due to a change in phosphorylation (Fig-
ure 5B) and examination of livers from
LPS+GalN-injected Tnfa/mice showed
that this change was TNFa dependent (Figure S4). The
LPS+GalN-inducedphosphorylationofBimdoesnot require cas-
pase activity, given that the shift in Bim mobility on SDS-PAGE
was not affected by prior administration of the pan-caspase
inhibitor Q-VD-oph (Figure 4A) or loss of caspase-8 in hepato-
cytes (Figure 4B).
The proapoptotic activity of Bim can be regulated by its
sequestration to microtubules by binding to the dynein motor
complex (Puthalakath et al., 1999), and JNK-mediated phos-
phorylation was reported to cause release and activation of
Bim in response to certain stress stimuli (Lei and Davis, 2003;
Putcha et al., 2003).We therefore performed subcellular fraction-
ation to examine whether the phosphorylation of Bim seen after
LPS+GalN injection affected its sequestration to the microtu-
bular-associated dynein motor complex. Immunoblot analysis
of the microtubule-enriched pellet and soluble fractions revealed
that the LPS+GalN-treatment-induced phosphorylated form of
Bim was released from the microtubular dynein motor complex
into the cytosol, whereas the unmodified form of Bim was
preferentially detected in the dynein-motor-complex-enriched
fraction (Figure 5C). Immunoblotting also revealed an increase
of phosphorylated (i.e., activated) JNK in livers of LPS+GalN-in-
jected mice (Figure 5D), and the mobility shift in Bim elicited byImmunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc. 59
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Roles of Caspase-8, Bid, and Bim in Hepatitisthis treatment was prevented by prior administration of the
synthetic JNK-inhibitory D-peptide, D-JNKI1 (Figure 5E). In
contrast, D-JNKI1 injection did not affect processing of Bid to
tBid (Figure 5E), demonstrating that this inhibitor did not interfere
with the LPS+GalN-induced production of TNFa or activation of
caspase-8. Importantly, injection of this JNK inhibitor reduced
LPS+GalN-induced hepatocyte destruction in Bid/ mice but
not in those lacking Bim (Figures 6A–6C), consistent with the
notion that JNK specifically regulates the proapoptotic activity
of Bim, which cooperates with Bid in hepatocyte killing. Collec-
tively, these results show that caspase-8-dependent activation
of Bid and JNK-induced activation of Bim cooperate in TNFa-
mediated hepatocyte destruction in LPS+GalN-injected mice.
Concanavalin A-Induced Hepatitis Requires Caspase-8
and Involves JNK-Mediated Activation of Bim
We next tested whether caspase-8 and the BH3-only proteins
Bid and Bim are also critical for hepatocyte killing and hepatitis
induced in different pathological settings. Injection of concanav-
alin A (ConA) into mice causes systemic activation of T lympho-
cytes resulting in fatal hepatitis that ismediated by TNFa (Kusters
et al., 1997; Trautwein et al., 1998).Whenmice lacking caspase-8
selectively in hepatocytes were challenged with ConA, they
Figure 3. Loss of BimCooperates with Loss
of Bid to Protect Mice from LPS+GalN-
Induced Hepatitis
(A) Mice of the indicated genotypes were injected
with 100 ng LPS plus 20 mg GalN. At the time
when the WT mice were sick (6 hr), all animals
were sacrificed and serum levels of ALT and AST
were measured. Each circle represents measure-
ments from an individual mouse. Horizontal bars
indicate the mean.
(B) Histological examination of H&E-stained liver
sections of mice of the indicated genotypes in-
jected 6 hr earlier with 100 ng LPS plus 20 mg
GalN (scale bars represent 50 mm). Pictures shown
are representative of the analysis of at least three
mice for each treatment and genotype.
(C) Table summarizing the long-term (followed up
to 5 days) survival of the indicated genotypes of
mice treated with 10 ng or 100 ng LPS plus
20 mg GalN. Mice that did not survive this treat-
ment all succumbed within 24 hr.
survived this treatment and showed only
minor elevation of serum ALT and AST
levels (Figure 7A) and retainednormal liver
structure (Figure 7B). In contrast, all litter-
mate controls succumbed to this treat-
ment within 6–8 hr, presenting at autopsy
with abnormally elevated serum levels of
ALT and AST (Figure 7A; caspase-8-defi-
cient versus control mice: p < 0.0035 for
both ALT and AST) and extensive disrup-
tion of liver architecture (Figure 7B).
In contrast to treatment with
LPS+GalN, loss of Bid did not confer
protection against ConA-induced hepa-
tocyte killing. However, similarly to
LPS+GalN injection, we observed rapid increases of phosphory-
lated (i.e., activated) JNK and phosphorylated Bim in livers of
mice challenged with ConA (Figures 7C–7E). This modification
in Bim could not be blocked by preadministration of the pan-cas-
pase inhibitor Q-VD-oph (Figure 7F) or specific loss of caspase-8
in hepatocytes (data not shown). Although mice lacking Bim or
both Bid and Bim had lower serum levels of ALT and AST
compared to ConA-injected WT or Bid/ mice, these enzymes
were still abnormally elevated (Figure 7G). Furthermore, disrup-
tion of liver architecture in Bcl2l11/ and Bcl2l11/Bid/
mice after 6 hr of treatment, although less severe compared to
WT or Bid/ mice (Figure 7H), eventually led to the death of all
Bcl2l11/ as well as Bcl2l11/Bid/mice. Collectively, these
results show that caspase-8 is essential and Bim a contributor
in ConA-induced hepatitis, another widely used model of
TNFa-mediated liver destruction.
DISCUSSION
Overstimulation of the immune system, either by pathogen-asso-
ciated molecular pattern (PAMP)-mediated activation of cells of
the innate immunesystemor antigenic stimulationof theadaptive
arm, plays amajor role in immunopathology of the liver as well as60 Immunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc.
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Roles of Caspase-8, Bid, and Bim in Hepatitiscertain other tissues. This damage is mediated to a large extent
through the proapoptotic activity of TNFa (Bradham et al.,
1998; Ding and Yin, 2004). The mechanisms by which TNFa kills
cells under these conditions remain unclear. Using the widely
employed LPS+GalNaswell as theConA injectionmodels of fatal
hepatitis, we defined an essential role for caspase-8 and impor-
Figure 4. Treatment with LPS+GalN Causes a Posttranslational
Modification of Bim that Does Not Require Caspase-8 or Other
Caspases
(A) Mice (WT), with or without pretreatment with 20 mg/kg of the pan-caspase
inhibitor Q-VD-oph, were injected with LPS (100 ng) plus GalN (20 mg) and
sacrificed 4 hr later. Total protein extracts from the livers of these animals
were probed by immunoblotting for Bim, Caspase-8, Bid, Caspase-7, and
active Caspase-3.
(B) Mice lacking caspase-8 in hepatocytes (C8: Albumin-Cre transgenic
Casp8fl/fl) and littermate controls (Albumin-Cre transgenic Casp8fl/wt) were
injected with 100 ng LPS plus 20 mg GalN and sacrificed after 4 hr. Total
protein extracts derived from the livers of these animals were probed by
immunoblotting for Bim or b-actin (loading control).tant contributory roles for the two proapoptotic BH3-only Bcl-2
familymembersBid andBim in TNFa-induced tissue destruction.
When higher levels of LPS (1000 ng) were administered or with
ConA injection, BH3-only proteinswere no longer limiting for fatal
hepatitis. In contrast, in another model of ‘‘death-receptor’’-
induced fatal hepatitis, mediated by Fas activation, Bid is essen-
tial for hepatocyte apoptosis (Kaufmann et al., 2007b; Yin et al.,
1999). What could be the reasons for these differences? We
speculate that differences in the requirement for Bid, Bim, and
possibly additional BH3-only proteins for hepatocyte destruction
inducedbydifferent death-receptor signalsmay arise fromdiffer-
ences in caspase-8 activity. A higher extent of caspase-8 activity
would be expected to cause more direct effector-caspase acti-
vation and may also increase apoptosis signaling through direct
cleavage of certain vital targets, thereby rendering this pathway
to hepatocyte apoptosis less dependent on Bid and other
BH3-only proteins (Figure S8). It appears likely that the reduction
in the caspase-8 inhibitor c-FLIP (Figure S9A), probably caused
by GalN-mediated blockade of its transcriptional inducer
NF-kB (Geisler et al., 2007), contributes to the finding that cas-
pase-8 can suffice for LPS+GalN-induced (TNFa-mediated)
hepatocyte killing even in the absence of Bid (and Bim). It cannot
be excluded that additional differences between TNFa- and
FasL-induced hepatocyte killing may arise from the ability of
TNF-R1 andTNF-R2 to trigger proapoptotic pathways in addition
to caspase-8 activation that are not activated by Fas (Figure S8).
Our genetic studies show that Bim andBid can both contribute
to TNFa-induced apoptosis signaling. The BH3-only proteins
Bim and Bid initiate apoptosis signaling through activation of
caspase-9 and consequent activation of effector caspases by
activating Bax and Bak, either directly and/or indirectly by block-
ing the prosurvival Bcl-2 family members that keep Bax and Bak
in check (Youle and Strasser, 2008). In response to TNFa, Bid is
activated by caspase-8-mediated proteolysis (Li et al., 1998; Luo
et al., 1998). Although caspase-mediated activation of BimEL has
been reported (Chen and Zhou, 2004), we found no evidence for
BimEL cleavage in livers of LPS+GalN-injected mice. Caspase-8
might theoretically contribute to Bim activation indirectly, such
as by cleaving a protein that controls its sequestration to micro-
tubules, a critical mode of Bim regulation (Puthalakath et al.,
1999), but we found no evidence for this (data not shown). Bim
does, however, not necessarily have to be activated by cas-
pase-8 to contribute to TNFa-induced apoptosis signaling. Any
TNFa-induced signal that activates Bim (see below) would be
expected to promote activation of caspase-9 and effector cas-
pases (either on its own or with tBid) because Bim is a potent
activator of Bax and Bak (Figure S8 and Youle and Strasser,
2008).
JNK has been implicated in TNFa-induced apoptosis signaling
and JNK-mediated phosphorylation has been implicated as
a trigger of the proapoptotic activity of Bim by causing its release
from sequestration to the microtubular dynein motor complex
(Lei and Davis, 2003; Putcha et al., 2003). Remarkably, a mobility
shift in BimEL, which was prevented by addition of a highly
specific JNK inhibitor, and a redistribution of the posttranslation-
allymodifiedBim frommicrotubules to thecytosolwere observed
in livers frommice injected with LPS+GalN or ConA. Importantly,
injection of the JNK inhibitor reduced LPS+GalN-induced hepa-
tocyte killing in Bid/ mice but not in Bcl2l11/ mice, whichImmunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc. 61
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Roles of Caspase-8, Bid, and Bim in HepatitisFigure 5. Bim Is Phosphorylated by JNK
Kinase in the Livers of Mice Injected with
LPS+GalN
(A) WT mice were injected with LPS (100 ng) plus
GalN (20mg) and sacrificed at the time points indi-
cated. Levels and posttranslational modifications
of Bim were investigated in liver-derived total
protein extracts by immunoblotting. Probing with
an antibody to b-actin was used as a loading
control.
(B) WT mice were injected with LPS (100 ng) plus
GalN (20mg) and sacrificed after 3 hr. Total protein
extracts were prepared from the liver in the
absence of phosphatase inhibitors and left
untreated or treated in vitro with l-phosphatase
prior to analyzing Bim modifications by immuno-
blotting.
(C) Mice were treated with GalN (20 mg) alone
(controls) or with LPS (100 ng) plus GalN (20 mg)
and livers harvested after 4 hr. Protein extracts
were prepared and then subjected to subcellular
fractionation into the dynein enriched pellet frac-
tion (P), containing BimEL/L sequestered to micro-
tubules, and a soluble fraction (S) containing free
cytosolic Bim. Fractions were analyzed by immu-
noblotting with antibodies to Bim or HSP70
(control for the purity of the fractions).
(D) Liver extracts fromWTmice treatedwith 100 ng
LPS plus 20 mg GalN for 4 hr were probed by
immunoblottingwith an antibody specific for phos-
phorylated (activated) JNK and the membrane
reprobed with an antibody to total JNK (loading
control).
(E) WT mice that had either been left untreated or
pretreated for 30 min with the JNK inhibitory
peptide D-JNKI1 (20 mg/kg, i.p.) were treated for
4 hr with either 20 mg GalN or with 100 ng LPS
plus 20 mg GalN. Total liver extracts were probed
by immunoblotting with antibodies to Bim (two
blots from independent experiments shown), Bid,
Mcl-1, and b-actin (loading control). Asterisks
indicate nonspecific bands.lack the proapoptotic effector activated by JNK. We therefore
conclude that JNK contributes to TNF-R1-induced apoptosis
signaling in hepatocytes of LPS+GalN-injectedmice by unleash-
ing the proapoptotic activity of Bim. ConA injection causes hepa-
tocyte killing through both secreted andmembrane-bound TNFa
and therefore involves both TNF-R1 and TNF-R2, whereas
LPS+GalN acts mainly through secreted TNFa, which signals
only through TNF-R1 (Grivennikov et al., 2005; Nowak et al.,
2000; Pfeffer et al., 1993; Rothe et al., 1993). The fact that
membrane-bound TNFa can activate JNK through not only
TNF-R1 but also TNF-R2 may therefore explain why Bim is more
important thanBid inConA-inducedhepatocytekilling (FigureS8).
In contrast to caspase-8 deficiency, combined loss of Bid and
Bim did not afford complete protection against LPS+GalN- or
ConA-induced hepatocyte destruction. Some Bcl2l11/Bid/
mice succumbed when injected with higher doses of LPS (e.g.,
100 ng) plus GalN, and even some of the long-term survivors
went through phases of sickness. Moreover, all Bcl2l11/ and
Bcl2l11/Bid/ mice injected with ConA became sick and
had to be sacrificed, although they exhibited less liver damage
than WT or Bid/ animals. This may indicate that proapoptotic62 Immunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc.proteins in addition to Bid and Bim (perhaps other BH3-only
proteins) contribute to LPS+GalN- and ConA-induced fatal
hepatitis. Theoretically, TNFa might also promote apoptosis by
causing a reduction in the amounts of prosurvival Bcl-2 family
members, but we found no significant changes in Mcl-1 or Bcl-
xL (the most highly expressed ones in hepatocytes), in animals
treated with LPS+GalN or ConA (Figures S2, S7, and S9B and
not shown). As discussed above, we prefer the hypothesis that
with increased caspase-8 activation (achieved by increased
TNFa-signaling due to increased levels of LPS or injection of
ConA), leading to increased direct activation of effector cas-
pases and cleavage of vital proteins, hepatocyte killing may
become independent of the BH3-only protein > Bax plus Bak >
Apaf-1 > Caspase-9 amplification mechanism for effector-
caspase activation (Figure S8). It is noteworthy that it has been
speculated that at high doses of LPS, other TNFa-mediated or
perhaps even TNFa-independent nonapoptotic death pathways
might also be activated in hepatocytes (Kamata et al., 2005). Our
experiments with mice lacking caspase-8 in hepatocytes imply,
however, that such processes would have to be caspase-8
dependent.
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Roles of Caspase-8, Bid, and Bim in HepatitisFigure 6. Inhibition of JNK Enhances Resistance of Bid-Deficient Mice to LPS+GalN-Induced Hepatocyte Destruction
(A)Mice of the genotypes indicatedwere injectedwith JNK inhibitory peptideD-JNKI1 (30mg/kg, i.p.) 30min prior to treatmentwith 10 ngLPS+GalNandwere then
monitored for survival for up to 72 hr. Mice injected with LPS+GalN served as controls. We calculated p values with a time-to-event analysis using a log-rank test.
(B) Table summarizing the long-term (followed up to 3 days) survival of mice of the indicated genotypes treated with 10 ng LPS+GalN, with or without pretreat-
ment with D-JNKI1. Mice that did not survive all succumbed to the treatment within 24 hr.
(C) Serum levels of ALT and AST in Bid/mice treated with 10 ng LPS plus 20 mg GalN, with or without pretreatment with D-JNKI1 (30 mg/ kg), were measured
after 6 hr. p values were as follows: WT versus Bid/: p (ALT) = 0.09; p (AST) = 0.16. Each circle represents an individual mouse. Horizontal bars indicate the
means of 8–11 mice for each genotype and are derived from three independent experiments.In conclusion, our results show that caspase-8 is essential and
the BH3-only proteins Bid and Bim are critical contributors in the
pathological killing of hepatocytes that is caused by TNFa
in vivo. These observations may have implications for diseases
characterized by hepatocellular destruction, indicating that
theymight respond to treatment with enzymatic inhibitors of cas-
pase-8 or compounds that can antagonize both Bid and Bim.
EXPERIMENTAL PROCEDURES
Mice
The generation and genotyping of Bid-deficient mice on an inbred C57BL/6
background has been described (Kaufmann et al., 2007b). Bcl2l11/ mice(Bouillet et al., 1999) were originally generated on a mixed C57BL/6x129SV
background by homologous recombination in 129SV-derived ES cells but
have been backcrossed for more than ten generations onto the C57BL/6 back-
ground. The Bcl2l11/Bid/ mice were generated by serially intercrossing
the two parental strains. Mice lacking caspase-8 selectively in hepatocytes
were generated by crossing mice with a loxP targeted Casp8 gene, generated
on amixed C57BL/6x129SV background and backcrossedwith C57BL/6mice
for threegenerations (Salmena et al., 2003)with transgenicmice expressing the
Cre recombinase under control of the hepatocyte-specific albumin promoter
(backcrossed onto C57BL/6 background for six generations). TRAIL-deficient
(Tnfsf10/) mice (Cretney et al., 2002) were generated by homologous recom-
bination in 129SV-derived ES cells and have been backcrossed for more than
ten generations onto the C57BL/6 background. TNF/ mice (generated with
C57BL/6 ES cells) (Korner et al., 1997) were obtained from H. Korner, JamesImmunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc. 63
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Roles of Caspase-8, Bid, and Bim in HepatitisFigure 7. Caspase-8 Is Essential and Bim a Contributor in ConA-Induced Hepatitis
(A) Mice lacking caspase-8 in hepatocytes (Albumin-Cre transgenicCasp8fl/fl) and littermate controls (Albumin-Cre transgenic Casp8fl/wtmice) were injected with
30 mg/kg ConA. At the time when the control mice were sick (8 hr), all animals were sacrificed and serum levels of ALT and AST were measured. Data shown
represent means ± SD of three to five mice for each genotype and each treatment.
(B) H&E-stained histological liver sections from mice treated as in (A). Pictures shown are representative of the analysis of at least three mice for each treatment
and genotype.
(C) Liver extracts fromWTmice treated with 30 mg/kg ConA for 4 hr were probed by immunoblotting with antibodies specific for phosphorylated (activated) JNK
or total JNK (loading control).
(D)WTmicewere injectedwith ConA (30mg/kg) and sacrificed at the time points indicated. Bim levels and possible posttranslationalmodificationswere analyzed
by immunoblotting of liver extracts as described in Figure 5A.
(E) WT mice were injected with 30 mg/kg ConA and sacrificed after 3 hr. Total protein extracts were prepared from the liver in the absence of phosphatase inhib-
itors and left untreated or treated in vitro with l-phosphatase prior to analyzing Bim modifications by immunoblotting.
(F) WT mice, with or without pretreatment with 20 mg/kg of the pan-caspase inhibitor Q-VD-oph, were injected with ConA (30 mg/kg) and sacrificed 5 hr later.
Total protein extracts from the livers of these animals were probed by immunoblotting for Bim.
(G) Mice of the genotypes indicated were injected with 30 mg/kg ConA. At the time when the WT mice were sick (6 hr), all animals were sacrificed
and serum levels of ALT and AST were measured. Each circle represents measurements from an individual mouse. Horizontal bars indicate the
mean.
(H) Histological examination of H&E-stained liver sections of mice of the indicated genotypes subjected for 6 hr to treatment with 30 mg/kg ConA (scale bars
represent 50 mm). Pictures shown are representative of the analysis of at least three mice for each genotype.Cook University, Townsville, Australia. C57BL/6 perforin/ mice (Ka¨gi et al.,
1994) were generated with C57BL/6 ES cells. C57BL/6 GranzymesABM/
mice were established by intercrossing C57BL/6 GranzymeM/ mice with
C57BL/6 GranzymesAB/ mice (Pao et al., 2005) (both strains generated64 Immunity 30, 56–66, January 16, 2009 ª2009 Elsevier Inc.with 129Sv ES cells and backcrossed to C57BL/6 for >12 and 8 generations,
respectively). All experiments with mice were performed according to the
guidelines of the animal ethics committees of the Melbourne Health Research
Directorate or the Ontario Cancer Institute.
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For Fas-mediated hepatitis, mice were injected intravenously (i.v.) with
0.25 mg/g body-weight recombinant soluble Fas ligand (FLAG-tagged, Apo-
tech) that had been crosslinked with 2 mg FLAG antibody (M2, SIGMA) per
mg of FasL. For the LPS+GalN model, mice were injected intraperitoneally
(i.p.) with 10, 100, or 1000 ng LPS (DIFCO) in the presence of 20 mg of the
liver-specific transcriptional inhibitor D-(+)-galactosamine (GalN, SIGMA).
For T cell-activation-mediated hepatitis, mice were injected i.v. with 30 mg/kg
body weight of ConA (SIGMA). For biochemical studies, at the time when WT
mice succumbed to these treatments, all mice of an experimental group were
sacrificed and bled (for serum analysis of liver enzymes), and the livers were
removed for histological analysis. For survival analysis, mice were treated as
indicated and monitored until becoming terminally ill. Statistical analyses
were performed by applying a two-tailed unpaired t test. The pan-caspase
inhibitor Q-VD-oph (MP Biomedicals) was administered i.p. at 20 mg/kg,




Shanghai Ltd) was administered i.p. at 30 mg/kg, 30 min prior to LPS/GalN
injection.
Immunoblotting and Caspase-Activity Assays
Mouse livers were surgically removed and cell suspensions were prepared by
passing them through a stainless-steel sieve. Red blood cells were lysed in
a hypotonic buffer and hepatocyte lysates prepared in a buffer containing
20mMTris/HCl (pH 7.4), 135mMNaCl, 1.5 mMMgCl2, 1mMEGTA, 1%Triton
X-100, 10% glycerol, 500 mg/mL Pefabloc (AEBSF), 1 mg/mL Leupeptin, 1 mg/
mL Aprotinin, 1 mg/mL Pepstatin, 100 mg/mL soybean trypsin inhibitor, and
2 mg/mL E64. Proteins (40 mg) in cell lysates were size-separated on precast
12% SDS PAGE gradient gels (Invitrogen). Membranes were probed with
a rat Bid monoclonal antibody (clone 2D1, Alexis; Kaufmann et al., 2007b),
a polyclonal rabbit Bim antibody (Stressgen), a rat anti-mouse caspase-8
monoclonal antibody (clone 1G12, Alexis; O’Reilly et al., 2004), a rabbit poly-
clonal antibody to active caspase-3 (Cell Signaling), a mouse monoclonal
antibody to caspase-7 (gift from Y. Lazebnik), a rat monoclonal antibody to
c-FLIP (clone Dave-2, Alexis), a rabbit polyclonal antibody toMcl-1 (Rockland),
amousemonoclonal antibody to phospho-JNK, or a rabbit polyclonal antibody
to JNK (both fromCell Signaling). Probingwith amousemonoclonal antibody to
b-actin (SIGMA, AC-40) served as a loading control.
A fluorogenic assay for effector-caspase activity in liver extracts was
performed according to the manufacturer’s (Bachem, Switzerland) protocols.
Subcellular Fractionation
Subcellular fractionation was performed as described earlier (Puthalakath
et al., 1999). In brief, 5 3 106 liver cells from mice injected with PBS, GalN,
or LPS+GalN were lysed in 500 ml of extraction buffer (0.05 M PIPES-NaOH,
0.05 M HEPES [pH 7.0], 2 mM MgCl2, 1 mM EDTA, 1 mM DTT plus protease,
and phosphatase inhibitors) containing 1%Triton X-100. Cell debris and nuclei
were removed by centrifugation at 500 3 g. The supernatant was spun at
125,000 3 g for 60 min at 4C and the filamentous actin-enriched pellet (P1)
was discarded. The remaining supernatant was incubated for 13 min at
37C with 20 mM taxol and 5 U apyrase (Sigma). This mixture was gently laid
on top of 0.5 ml 7.5% sucrose (in extraction buffer) and centrifuged for
30 min at 125,000 3 g at 30C. The sedimented pellet was saved as the
dynein-enriched P2 fraction and the supernatant as the S fraction.
SUPPLEMENTAL DATA
Supplemental Data include nine figures and can be found with this article
online at http://www.immunity.com/supplemental/S1074-7613(08)00543-8.
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